Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02SWF
|
|||
Former ID |
DNC011830
|
|||
Drug Name |
(1R,2R)-2-(1H-Imidazol-4-yl)-1-methyl-propylamine
|
|||
Synonyms |
CHEMBL40378; (1R,2R)-2-(1H-Imidazol-4-yl)-1-methyl-propylamine; BDBM50034706; AKOS006360607
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C7H13N3
|
|||
Canonical SMILES |
CC(C1=CN=CN1)C(C)N
|
|||
InChI |
1S/C7H13N3/c1-5(6(2)8)7-3-9-4-10-7/h3-6H,8H2,1-2H3,(H,9,10)/t5-,6-/m1/s1
|
|||
InChIKey |
QQTWSOMOTYJIQP-PHDIDXHHSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Histamine receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Monoamine Transport | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | A novel pyrrolidine analog of histamine as a potent, highly selective histamine H3 receptor agonist. J Med Chem. 1995 May 12;38(10):1593-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.